Validation of an Integrated Genetic‐Epigenetic Test for the Assessment of Coronary Heart Disease
Background Coronary heart disease (CHD) is the leading cause of death in the world. Unfortunately, many of the key diagnostic tools for CHD are insensitive, invasive, and costly; require significant specialized infrastructure investments; and do not provide information to guide postdiagnosis therapy...
Main Authors: | Robert Philibert, Timur K. Dogan, Stacey Knight, Ferhaan Ahmad, Stanley Lau, George Miles, Kirk U. Knowlton, Meeshanthini V. Dogan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-11-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.030934 |
Similar Items
-
The Reversion of the Epigenetic Signature of Coronary Heart Disease in Response to Smoking Cessation
by: Robert Philibert, et al.
Published: (2023-06-01) -
Array-Based Epigenetic Aging Indices May Be Racially Biased
by: Robert Philibert, et al.
Published: (2020-06-01) -
Epigenetics and Heart Failure
by: Syeda Shegufta Ameer, et al.
Published: (2020-11-01) -
Epigenetics and Congenital Heart Diseases
by: Léa Linglart, et al.
Published: (2022-06-01) -
Epigenetics in Congenital Heart Disease
by: Guanglei Wang, et al.
Published: (2022-04-01)